oligoastrocytoma
Showing 1 - 25 of 97
Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial
Recruiting
- Glioblastoma
- +8 more
- Intra-arterial Cetuximab
- +2 more
-
New York, New YorkLenox Hill Brain Tumor Center
Oct 17, 2022
Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,
Recruiting
- Anaplastic Astrocytoma, IDH-Wildtype
- +8 more
- Quality-of-Life Assessment
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 8, 2022
Anaplastic Oligoastrocytoma, Glioblastoma Trial in Guangzhou (Temozolomide)
Recruiting
- Anaplastic Oligoastrocytoma
- Glioblastoma
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Oct 27, 2022
Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an
Completed
- Glioma
- +7 more
- Neural stem cells loaded with an oncolytic adenovirus
-
Duarte, California
- +1 more
Dec 28, 2022
Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Mixed Glioma Trial in Minneapolis, Portland (Carboplatin, Etoposide,
Completed
- Anaplastic Oligoastrocytoma
- +3 more
- Carboplatin
- +7 more
-
Minneapolis, Minnesota
- +1 more
Mar 11, 2022
Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after
Active, not recruiting
- Oligodendroglioma
- +5 more
- GBM6-AD and poly-ICLC before and after surgery
- GBM6-AD and poly-ICLC after surgery only
-
San Francisco, CaliforniaUniversity of California
Sep 20, 2022
Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte
Withdrawn
- Recurrent Anaplastic Astrocytoma
- +7 more
- Neural Stem Cells-expressing CRAd-S-pk7
- Resection
- (no location specified)
Nov 22, 2022
MicroRNA-10b in Patients With Gliomas
Recruiting
- Astrocytoma
- +8 more
-
Boston, Massachusetts
- +3 more
May 30, 2021
Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte
Active, not recruiting
- Recurrent Anaplastic Astrocytoma
- +6 more
- Carboxylesterase-expressing Allogeneic Neural Stem Cells
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 7, 2022
Glioma, Pilocytic Astrocytoma, Anaplastic Astrocytoma Trial in Saint Louis (MRI-guided laser ablation, Doxorubicin, Etoposide)
Recruiting
- Glioma
- +8 more
- MRI-guided laser ablation
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 22, 2022
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma Trial in Duarte (biological,
Completed
- Adult Anaplastic Astrocytoma
- +6 more
- E. coli CD-expressing genetically modified neural stem cells
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 28, 2021
Oligodendroglioma; Oligoastrocytoma Trial in Marseille (Bis-Chloroethyl-Nitroso-Urea (BCNU) withTemozolomide)
Completed
- Oligodendroglioma; Oligoastrocytoma
- Bis-Chloroethyl-Nitroso-Urea (BCNU) withTemozolomide
-
Marseille, FranceAssistance Publique - Hôpitaux de Marseille
Feb 11, 2021
Glioblastoma Multiforme, Anaplastic Oligoastrocytoma Trial in United States (Ad-RTS-hIL-12, veledimex)
Completed
- Glioblastoma Multiforme
- Anaplastic Oligoastrocytoma
- Ad-RTS-hIL-12
- veledimex
-
Los Angeles, California
- +5 more
Sep 21, 2021
Oligoastrocytoma, Astrocytoma, Oligodendroglioma Trial (device, procedure, other)
Completed
- Oligoastrocytoma
- +2 more
- fMRI
- +2 more
- (no location specified)
Sep 1, 2020
Anaplastic Oligodendroglioma, Oligoastrocytoma, Oligodendroglioma Trial in Los Angeles (Wear novoTTF-200A, Quality-of-Life
Withdrawn
- Anaplastic Oligodendroglioma
- +2 more
- Wear novoTTF-200A
- Quality-of-Life Assessment
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Dec 8, 2020
Adult Diffuse Astrocytoma, Adult Mixed Glioma, Adult Oligodendroglioma Trial in Los Angeles (tumor lysate-pulsed autologous
Completed
- Adult Diffuse Astrocytoma
- +4 more
- tumor lysate-pulsed autologous dendritic cell vaccine
- laboratory biomarker analysis
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Oct 14, 2020
Oligodendroglioma, Oligoastrocytoma Trial in Spain (Palbociclib)
Completed
- Oligodendroglioma
- Oligoastrocytoma
-
Las Palmas de Gran Canaria, Las Palmas, Spain
- +10 more
Apr 1, 2020
Glioblastoma Multiforme, Anaplastic Astrocytoma, Oligoastrocytoma, Mixed Trial in United States (Interferon-beta)
Completed
- Glioblastoma Multiforme
- +3 more
- Interferon-beta
-
Birmingham, Alabama
- +4 more
Nov 13, 2020
Childhood Choroid Plexus Tumor, Childhood Ependymoblastoma, Childhood Grade III Meningioma Trial in United States (palbociclib
Terminated
- Childhood Choroid Plexus Tumor
- +18 more
- palbociclib isethionate
- +2 more
-
Los Angeles, California
- +10 more
Feb 10, 2021
Central Nervous System Tumors for National Cancer Institute s
Terminated
- Glioblatoma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 6, 2019
Brain and CNS Tumors Trial in Canada (topotecan HCl)
Completed
- Brain and Central Nervous System Tumors
- topotecan hydrochloride
-
Calgary, Alberta, Canada
- +10 more
Apr 7, 2020
Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)
Active, not recruiting
- Brain and Central Nervous System Tumors
- +9 more
- DNA analysis
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 28, 2021
CNS Tumors, Brain Tumor Trial in Cleveland (temozolomide)
Completed
- Central Nervous System Tumors
- Brain Tumor
-
Cleveland, OhioCase Comprehensive Cancer Center
Sep 14, 2018
Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Diffuse Intrinsic Pontine Glioma Trial in Australia, Canada, United States
Completed
- Anaplastic Astrocytoma
- +3 more
- 3-Dimensional Conformal Radiation Therapy
- +3 more
-
Birmingham, Alabama
- +179 more
Oct 5, 2021